Granted Patent
B2
US 10,568,887 · App. 15/750,151 · Granted Feb 25, 2020
Combination therapies for treatment of cancer
Inventors:
David J. Bearss (Alpine, UT); Steven L. Warner (Sandy, UT); Adam Siddiqui-Jain (South Jordan, UT); Clifford J. Whatcott (West Jordan, UT); Wontak Kim (Lehi, UT)
Assignee:
Tolero Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Combination therapies for treatment of cancer are provided. The disclosed methods comprise administration of a cyclin-dependent kinase inhibitor and a DNA methyltransferase inhibitor to a mammal in need thereof.
Claims (1)
1. A method of treating myelodysplastic syndrome (MDS) comprising administering a therapeutically effective amount of decitabine and subsequently a therapeutically effective amount of alvocidib to a human in need thereof.
Assignments (4)
CHANGE OF NAME
Recorded Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →
MERGER
Recorded Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053181/0114 →
CHANGE OF NAME
Recorded Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053181/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 24, 2018
From: BEARSS, DAVID J.; WARNER, STEVEN L.; SIDDIQUI-JAIN, ADAM; WHATCOTT, CLIFFORD J.; KIM, WONTAK
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 045626/0176 →
Continuity (2)
Provisional Application
62200499
· Aug 3, 2015
Cited By (1)